2021 Q3 Form 10-Q Financial Statement

#000131472721000032 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q2 2020 Q1
Revenue $378.7M $249.3M $175.1M
YoY Change -4.16% -16.69%
Cost Of Revenue $200.8M $139.5M $102.1M
YoY Change -2.26% -14.76%
Gross Profit $177.9M $109.8M $73.01M
YoY Change -6.46% -19.25%
Gross Profit Margin 46.97% 44.04% 41.7%
Selling, General & Admin $105.6M $108.9M $76.62M
YoY Change 23.7% 4.57%
% of Gross Profit 59.35% 99.22% 104.95%
Research & Development $55.58M $57.77M $49.59M
YoY Change 30.24% 23.74%
% of Gross Profit 31.25% 52.62% 67.93%
Depreciation & Amortization $9.089M $8.900M $9.700M
YoY Change 5.95% 6.59%
% of Gross Profit 5.11% 8.11% 13.29%
Operating Expenses $161.1M $166.7M $126.2M
YoY Change 25.89% 11.35%
Operating Profit $16.73M -$56.91M -$53.21M
YoY Change 278.17% 131.96%
Interest Expense $77.00K $360.0K $374.0K
YoY Change -42.49% -39.29%
% of Operating Profit 0.46%
Other Income/Expense, Net $1.955M $86.00K -$923.0K
YoY Change -95.41% 832.32%
Pretax Income $18.68M -$56.83M -$54.13M
YoY Change 331.3% 134.97%
Income Tax $900.0K $200.0K -$1.800M
% Of Pretax Income 4.82%
Net Earnings $17.83M -$56.98M -$52.32M
YoY Change 306.74% 129.23%
Net Earnings / Revenue 4.71% -22.86% -29.88%
Basic Earnings Per Share $0.14 -$0.52 -$0.48
Diluted Earnings Per Share $0.12 -$0.52 -$0.48
COMMON SHARES
Basic Shares Outstanding 125.1M 109.5M shares 109.5M shares
Diluted Shares Outstanding 144.2M 109.5M shares 109.5M shares

Balance Sheet

Concept 2021 Q3 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $670.9M $329.1M $283.3M
YoY Change -2.72% -4.06%
Cash & Equivalents $670.9M $329.1M $283.3M
Short-Term Investments
Other Short-Term Assets $23.76M $19.10M $28.10M
YoY Change 22.44% 78.98%
Inventory $146.7M $88.44M $112.5M
Prepaid Expenses
Receivables $70.33M $50.36M $40.17M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $911.7M $487.0M $464.0M
YoY Change -14.01% -3.09%
LONG-TERM ASSETS
Property, Plant & Equipment $71.73M $64.84M $74.91M
YoY Change -11.0% 4.68%
Goodwill $15.55M $15.55M $15.55M
YoY Change
Intangibles $24.96M $26.78M $27.14M
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.82M $5.759M $2.297M
YoY Change 59.66% -34.52%
Total Long-Term Assets $172.4M $157.6M $175.2M
YoY Change 103.31% 131.86%
TOTAL ASSETS
Total Short-Term Assets $911.7M $487.0M $464.0M
Total Long-Term Assets $172.4M $157.6M $175.2M
Total Assets $1.084B $644.6M $639.2M
YoY Change 0.11% 15.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $198.5M $106.5M $82.11M
YoY Change -30.6% -4.6%
Accrued Expenses $77.01M $47.75M $43.04M
YoY Change 2.55% 34.73%
Deferred Revenue $16.91M $14.73M $14.59M
YoY Change 10.35% 12.98%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $8.333M $8.333M
YoY Change -28.58% -16.67%
Total Short-Term Liabilities $400.9M $257.7M $213.2M
YoY Change -6.46% 14.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $19.90M $21.55M
YoY Change -29.33% -27.7%
Other Long-Term Liabilities $3.677M $7.187M $2.676M
YoY Change -20.85% -72.0%
Total Long-Term Liabilities $3.677M $27.08M $24.22M
YoY Change -27.26% -38.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $400.9M $257.7M $213.2M
Total Long-Term Liabilities $3.677M $27.08M $24.22M
Total Liabilities $497.0M $383.4M $339.4M
YoY Change 7.86% 26.88%
SHAREHOLDERS EQUITY
Retained Earnings -$61.15M -$246.9M -$189.9M
YoY Change 38.11% 15.27%
Common Stock $128.0K $115.0K $113.0K
YoY Change 7.48% 6.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $48.74M $53.32M $51.31M
YoY Change 347.89% 340.88%
Treasury Stock Shares
Shareholders Equity $587.1M $261.2M $299.8M
YoY Change
Total Liabilities & Shareholders Equity $1.084B $644.6M $639.2M
YoY Change 0.11% 15.3%

Cashflow Statement

Concept 2021 Q3 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $17.83M -$56.98M -$52.32M
YoY Change 306.74% 129.23%
Depreciation, Depletion And Amortization $9.089M $8.900M $9.700M
YoY Change 5.95% 6.59%
Cash From Operating Activities $70.74M $47.80M -$83.40M
YoY Change 4.37% 208.89%
INVESTING ACTIVITIES
Capital Expenditures -$14.89M -$4.100M -$9.900M
YoY Change -31.67% 266.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$700.0K
YoY Change
Cash From Investing Activities -$14.89M -$4.100M -$10.60M
YoY Change -31.67% 292.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.77M 1.500M -29.80M
YoY Change -46.43% -266.48%
NET CHANGE
Cash From Operating Activities 70.74M 47.80M -83.40M
Cash From Investing Activities -14.89M -4.100M -10.60M
Cash From Financing Activities -24.77M 1.500M -29.80M
Net Change In Cash 31.08M 45.20M -123.8M
YoY Change 6.1% 949.15%
FREE CASH FLOW
Cash From Operating Activities $70.74M $47.80M -$83.40M
Capital Expenditures -$14.89M -$4.100M -$9.900M
Free Cash Flow $85.63M $51.90M -$73.50M
YoY Change 0.19% 202.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001314727
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-02
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
dei Document Type
DocumentType
10-Q
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SONOS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-07-03
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38603
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0479476
dei Entity Address Address Line1
EntityAddressAddressLine1
614 Chapala Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Barbara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93101
dei City Area Code
CityAreaCode
805
dei Local Phone Number
LocalPhoneNumber
965-3001
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SONO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
125771272 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
670905000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
407100000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
191000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70329000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54935000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
146697000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
180830000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23763000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17321000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
911694000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
660377000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71732000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45049000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66041000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60784000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36595000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42342000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
15545000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
15545000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24962000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26394000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1747000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1800000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21823000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8809000 USD
CY2021Q3 us-gaap Assets
Assets
1084098000 USD
CY2020Q4 us-gaap Assets
Assets
816051000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
198495000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
250328000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
77006000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44517000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
0 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
6667000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16906000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15304000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42471000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31150000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
400919000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
393015000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36501000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50360000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18251000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
53480000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
47085000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2394000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2434000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3677000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7067000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
496971000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
518212000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
128000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
114000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
48740000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
20886000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
698520000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
548993000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61153000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228492000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1628000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1890000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
587127000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
297839000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1084098000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816051000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
249310000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
986491000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200811000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
139519000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
714142000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
576071000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
177861000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
109791000 USD
us-gaap Gross Profit
GrossProfit
643062000 USD
us-gaap Gross Profit
GrossProfit
410420000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55578000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57770000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164294000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
159890000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
67231000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
77273000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
198888000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
205201000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38323000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31662000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
113372000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87989000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
161132000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
166705000 USD
us-gaap Operating Expenses
OperatingExpenses
476554000 USD
us-gaap Operating Expenses
OperatingExpenses
453080000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16729000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56914000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
166508000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-42660000 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
81000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
114000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1954000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
77000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
360000 USD
us-gaap Interest Expense
InterestExpense
525000 USD
us-gaap Interest Expense
InterestExpense
1187000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1998000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
365000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4678000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3366000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1955000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
86000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4267000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4133000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18684000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56828000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
170775000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38527000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
858000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3436000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-56980000 USD
us-gaap Net Income Loss
NetIncomeLoss
167339000 USD
us-gaap Net Income Loss
NetIncomeLoss
-38526000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17826000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56980000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
167339000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38526000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
17826000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-56980000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
167339000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-38526000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144181632 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109477622 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125138279 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109477622 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120876472 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109325785 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139293775 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109325785 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-56980000 USD
us-gaap Net Income Loss
NetIncomeLoss
167339000 USD
us-gaap Net Income Loss
NetIncomeLoss
-38526000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-784000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
219000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
262000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-731000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17042000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56761000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
167601000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39257000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
297839000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
69505000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5118000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14844000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
847000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
510209000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49661000 USD
CY2021Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
682000 USD
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13703000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16363000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
17221000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
199000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
579268000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12371000 USD
CY2021Q3 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21047000 USD
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
16054000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15547000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-784000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
587127000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
280928000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7969000 USD
CY2019Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2926000 USD
CY2019Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2152000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13204000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2444000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
70775000 USD
CY2019Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-519000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
367279000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4616000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30290000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13394000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-52320000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-431000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
299804000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5122000 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2007000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15041000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-56980000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
219000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
261199000 USD
us-gaap Net Income Loss
NetIncomeLoss
167339000 USD
us-gaap Net Income Loss
NetIncomeLoss
-38526000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25789000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27692000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2789000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14047000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
46755000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41638000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1253000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
4371000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
95000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-176000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2226000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1491000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13846000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-53418000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32333000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-129623000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
17730000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4400000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-27169000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-162137000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
21501000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
8038000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7715000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3506000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2143000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7548000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246741000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83151000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34792000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29905000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36289000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34792000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66194000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
25000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
5000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21729000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33216000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
131536000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17708000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
34877000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
6603000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49930000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27111000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1735000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
639000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
263614000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9515000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
407291000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338820000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
670905000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
329305000 USD
us-gaap Interest Paid Net
InterestPaidNet
434000 USD
us-gaap Interest Paid Net
InterestPaidNet
1318000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3773000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1153000 USD
sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
15078000 USD
sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
11689000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9046000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3055000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1622000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
75913000 USD
CY2021Q3 sono Numberof Countries Where Products Distributed
NumberofCountriesWhereProductsDistributed
50 country
us-gaap Use Of Estimates
UseOfEstimates
<div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates and judgments</span></div><div><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the outbreak of the novel coronavirus (COVID-19) was declared a pandemic. While the nature of the situation is dynamic, the Company has considered the impact when developing its estimates and assumptions noted above. Actual results and outcomes may differ from management's estimates and assumptions.</span></div>
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
249310000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
986491000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
249310000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
986491000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378672000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
249310000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357204000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
986491000 USD
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
86540000 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
73757000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1477000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1307000 USD
CY2021Q3 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
14734000 USD
CY2020Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
17515000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70329000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54935000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
132784000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
172184000 USD
CY2021Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
13913000 USD
CY2020Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
8646000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
146697000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
180830000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7852000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2990000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4862000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P2Y10M13D
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27952000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2990000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24962000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
488000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1936000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1248000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1020000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
170000 USD
CY2021Q3 sono Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4862000 USD
CY2021Q3 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
17122000 USD
CY2020Q4 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
10609000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
12023000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6252000 USD
CY2021Q3 sono Accrued Inventory Current
AccruedInventoryCurrent
16747000 USD
CY2020Q4 sono Accrued Inventory Current
AccruedInventoryCurrent
2843000 USD
CY2021Q3 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
13958000 USD
CY2020Q4 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
9753000 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11000000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
10068000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6156000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5524000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
77006000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45049000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
62388000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56449000 USD
sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
13381000 USD
sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
10210000 USD
sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
21379000 USD
sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
14126000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
70386000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
60365000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4624000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
16157000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14229000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12178000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23198000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
70386000 USD
CY2021Q3 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
19758000 USD
CY2020Q4 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
14195000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10734000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10910000 USD
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5233000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3628000 USD
CY2021Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
6746000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2417000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42471000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31150000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3628000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3254000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
12218000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9609000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10613000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
9657000 USD
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5233000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3206000 USD
CY2020Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.024
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
82000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
24918000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6667000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18251000 USD
CY2021Q3 sono Debt Instrument Fixed Charge Ratio Covenant One1
DebtInstrumentFixedChargeRatioCovenantOne1
1.0
CY2021Q3 sono Debt Instrument Fixed Charge Ratio Covenant Two
DebtInstrumentFixedChargeRatioCovenantTwo
1.15
CY2021Q3 us-gaap Receivable For Recovery Of Import Duties Net
ReceivableForRecoveryOfImportDutiesNet
22500000 USD
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000.0 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
643567 shares
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
21700000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
33.74
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28300000 USD
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
1424061 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
28422940 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.03
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
99053000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11992137 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
441379 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.37
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15989424 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
370365000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
13737886 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
322318000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
15777683 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
365799000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15547000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15041000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46755000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41638000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
17826000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-56980000 USD
us-gaap Net Income Loss
NetIncomeLoss
167339000 USD
us-gaap Net Income Loss
NetIncomeLoss
-38526000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125138279 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109477622 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120876472 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109325785 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144181632 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109477622 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139293775 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109325785 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8653315 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43017722 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14001689 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42759302 shares
CY2021Q3 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
1800000 USD
CY2020Q2 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
1400000 USD
us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
5300000 USD
us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
4500000 USD

Files In Submission

Name View Source Status
0001314727-21-000032-index-headers.html Edgar Link pending
0001314727-21-000032-index.html Edgar Link pending
0001314727-21-000032.txt Edgar Link pending
0001314727-21-000032-xbrl.zip Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit101001.jpg Edgar Link pending
exhibit101002.jpg Edgar Link pending
exhibit101003.jpg Edgar Link pending
exhibit101004.jpg Edgar Link pending
exhibit101005.jpg Edgar Link pending
exhibit101006.jpg Edgar Link pending
exhibit101007.jpg Edgar Link pending
exhibit101008.jpg Edgar Link pending
exhibit101009.jpg Edgar Link pending
exhibit101010.jpg Edgar Link pending
exhibit101011.jpg Edgar Link pending
exhibit101012.jpg Edgar Link pending
exhibit101013.jpg Edgar Link pending
exhibit101014.jpg Edgar Link pending
exhibit101015.jpg Edgar Link pending
exhibit101016.jpg Edgar Link pending
exhibit101017.jpg Edgar Link pending
exhibit101018.jpg Edgar Link pending
exhibit101019.jpg Edgar Link pending
exhibit101020.jpg Edgar Link pending
exhibit101021.jpg Edgar Link pending
exhibit101022.jpg Edgar Link pending
exhibit101023.jpg Edgar Link pending
exhibit101024.jpg Edgar Link pending
exhibit101025.jpg Edgar Link pending
exhibit101026.jpg Edgar Link pending
exhibit101027.jpg Edgar Link pending
exhibit101028.jpg Edgar Link pending
exhibit101029.jpg Edgar Link pending
exhibit101030.jpg Edgar Link pending
exhibit101031.jpg Edgar Link pending
exhibit101032.jpg Edgar Link pending
exhibit101033.jpg Edgar Link pending
exhibit101034.jpg Edgar Link pending
exhibit101035.jpg Edgar Link pending
exhibit101036.jpg Edgar Link pending
exhibit101037.jpg Edgar Link pending
exhibit101038.jpg Edgar Link pending
exhibit101039.jpg Edgar Link pending
exhibit101040.jpg Edgar Link pending
exhibit101041.jpg Edgar Link pending
exhibit101042.jpg Edgar Link pending
exhibit101043.jpg Edgar Link pending
exhibit101044.jpg Edgar Link pending
exhibit101045.jpg Edgar Link pending
exhibit101046.jpg Edgar Link pending
exhibit101047.jpg Edgar Link pending
exhibit101048.jpg Edgar Link pending
exhibit101049.jpg Edgar Link pending
exhibit101050.jpg Edgar Link pending
exhibit101051.jpg Edgar Link pending
exhibit101052.jpg Edgar Link pending
exhibit101053.jpg Edgar Link pending
exhibit101054.jpg Edgar Link pending
exhibit101055.jpg Edgar Link pending
exhibit101056.jpg Edgar Link pending
exhibit101057.jpg Edgar Link pending
exhibit101058.jpg Edgar Link pending
exhibit101059.jpg Edgar Link pending
exhibit101060.jpg Edgar Link pending
exhibit101061.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q3fy21exhibit311ceo302.htm Edgar Link pending
q3fy21exhibit312cfo302.htm Edgar Link pending
q3fy21exhibit321ceo906.htm Edgar Link pending
q3fy21exhibit322cfo906.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sono-20210703.htm Edgar Link pending
sono-20210703.xsd Edgar Link pending
sono-20210703_cal.xml Edgar Link unprocessable
sono-20210703_def.xml Edgar Link unprocessable
sono-20210703_htm.xml Edgar Link completed
sono-20210703_lab.xml Edgar Link unprocessable
sono-20210703_pre.xml Edgar Link unprocessable